Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Exclusion Criteria
- With brain metastasis
- With uncontrollable large pleural or peritoneal effusion
- Malignant tumour of the past five years with other organizations to source, but the full treatment of cervical carcinoma in situ and except skin basal cell carcinoma and squamous cell carcinomas;
- ...
- With brain metastasis
- With uncontrollable large pleural or peritoneal effusion
- Malignant tumour of the past five years with other organizations to source, but the full treatment of cervical carcinoma in situ and except skin basal cell carcinoma and squamous cell carcinomas;
- Pregnancy or breast-feeding women
- Recurrence after transfer have received taxol or docetaxel as first-line chemotherapy,If the adjuvant chemotherapy with paclitaxel,From the last chemotherapy for 6 months or less
- Has a long history of chronic diarrhea, or now complete intestinal obstruction patients
- Severe uncontrolled medical disease or acute infection
- In the near future has a history of myocardial infarction (3 months)
Summary
- Conditions
- Advanced Gastric Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
from the first cycle of treatment (day one) to two month after the last cycle
from the first cycle of treatment (day one) to two month after the last cycle
Exclusion Criteria
- With brain metastasis
- With uncontrollable large pleural or peritoneal effusion
- Malignant tumour of the past five years with other organizations to source, but the full treatment of cervical carcinoma in situ and except skin basal cell carcinoma and squamous cell carcinomas;
- ...
- With brain metastasis
- With uncontrollable large pleural or peritoneal effusion
- Malignant tumour of the past five years with other organizations to source, but the full treatment of cervical carcinoma in situ and except skin basal cell carcinoma and squamous cell carcinomas;
- Pregnancy or breast-feeding women
- Recurrence after transfer have received taxol or docetaxel as first-line chemotherapy,If the adjuvant chemotherapy with paclitaxel,From the last chemotherapy for 6 months or less
- Has a long history of chronic diarrhea, or now complete intestinal obstruction patients
- Severe uncontrolled medical disease or acute infection
- In the near future has a history of myocardial infarction (3 months)
Tracking Information
- NCT #
- NCT02072317
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon